The report covers the period from January 1, 2022 to December 31, 2022, with some of the contents extending forward or backward moderately. The report considers the materiality, quantitative, balance and consistency of the key ESG performance indicators. The report includes a materiality assessment. The report includes a materiality matrix. The report includes a list of material items. The materiality items are ranked. The report highlights the company's commitment to sustainability, including efforts to improve ESG governance, innovate and empower the industry, ensure quality and patient safety, protect the environment and promote green development, care for its employees, give back to communities, and operate responsibly.
Issuing Company Alphamab Oncology
Report Type Sustainability Report
Report Language EN
Report Filesize 10 MB
No. of Pages 38 pages
Reporting periodJanuary 1, 2022-December 31, 2022
Report EditionUnknown
Assurance Provider Unknown
Reporting Standards GRI; SASB; UNSDGs
Materiality Assessmenttrue